HK1039336B - Process for preparing amine platinum complexes - Google Patents

Process for preparing amine platinum complexes Download PDF

Info

Publication number
HK1039336B
HK1039336B HK02100835.7A HK02100835A HK1039336B HK 1039336 B HK1039336 B HK 1039336B HK 02100835 A HK02100835 A HK 02100835A HK 1039336 B HK1039336 B HK 1039336B
Authority
HK
Hong Kong
Prior art keywords
solvent
pta
ptcl
amine
cis
Prior art date
Application number
HK02100835.7A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1039336A1 (en
Inventor
S. Y. Wong Ernest
M. Giandomenico Christen
Original Assignee
Anormed Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc. filed Critical Anormed Inc.
Publication of HK1039336A1 publication Critical patent/HK1039336A1/en
Publication of HK1039336B publication Critical patent/HK1039336B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK02100835.7A 1999-04-13 2000-04-11 Process for preparing amine platinum complexes HK1039336B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12893999P 1999-04-13 1999-04-13
US128939P 1999-04-13
PCT/CA2000/000385 WO2000061590A1 (en) 1999-04-13 2000-04-11 Process for preparing amine platinum complexes

Publications (2)

Publication Number Publication Date
HK1039336A1 HK1039336A1 (en) 2002-04-19
HK1039336B true HK1039336B (en) 2006-01-27

Family

ID=22437722

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100835.7A HK1039336B (en) 1999-04-13 2000-04-11 Process for preparing amine platinum complexes

Country Status (32)

Country Link
US (1) US6518428B1 (https=)
EP (1) EP1165576B1 (https=)
JP (1) JP4756669B2 (https=)
KR (1) KR100711955B1 (https=)
CN (3) CN1916009B (https=)
AR (1) AR043084A1 (https=)
AT (1) ATE309257T1 (https=)
AU (1) AU770006B2 (https=)
BG (1) BG65429B1 (https=)
BR (1) BR0009780B1 (https=)
CA (1) CA2368849C (https=)
CY (1) CY1104965T1 (https=)
CZ (1) CZ303156B6 (https=)
DE (1) DE60023859T2 (https=)
DK (1) DK1165576T3 (https=)
EE (1) EE04747B1 (https=)
ES (1) ES2253214T3 (https=)
HK (1) HK1039336B (https=)
HU (1) HUP0200748A3 (https=)
IL (1) IL145671A0 (https=)
IS (1) IS2711B3 (https=)
MX (1) MXPA01010430A (https=)
MY (1) MY122706A (https=)
NO (1) NO330429B1 (https=)
NZ (1) NZ514736A (https=)
PL (1) PL202731B1 (https=)
RU (1) RU2245340C2 (https=)
SK (1) SK286374B6 (https=)
TW (1) TWI289565B (https=)
UA (1) UA71614C2 (https=)
WO (1) WO2000061590A1 (https=)
ZA (1) ZA200107965B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
CN1916009B (zh) 1999-04-13 2010-12-15 阿诺麦德股份有限公司 制备胺铂配合物的方法
US6413953B1 (en) * 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6806289B1 (en) * 2000-07-14 2004-10-19 Stephen J. Lippard Coordination complexes, and methods for preparing by combinatorial methods, assaying and using the same
US6894049B1 (en) 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
PT1720540E (pt) 2004-02-18 2008-09-10 Gpc Biotech Ag Métodos de tratamento de tumores resistentes ou refractários
CZ2004964A3 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
ES2257178B1 (es) * 2004-09-30 2007-08-16 Universidad Autonoma De Madrid Compuestos de platino de formula trans-(ptc12(isopropilamina)(4-(hidroximetil)-piridina)) y trans-(ptc12(isopropilamina)(3-hidroximetil)-piridina y su aplicacion como farmaco antitumoral.
RU2298556C1 (ru) * 2005-11-17 2007-05-10 Общество с ограниченной ответственностью "ЦитоСтарт" Триметилоламинометановая соль цис-бис [4-нитраминопиридин-n] тетрахлороплатины (iv) и способ ее получения
RU2309158C1 (ru) * 2006-03-27 2007-10-27 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Способ получения цис-дихлороамминизопропиламинплатины (ii)
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
US20100310661A1 (en) * 2007-07-16 2010-12-09 Poniard Pharmaceuticals, Inc. Oral formulations for picoplatin
CA2715348A1 (en) * 2008-02-08 2009-08-13 Poniard Pharmaceuticals, Inc. Use of picoplatin and bevacizumab to treat colorectal cancer
US20120123121A1 (en) * 2009-06-12 2012-05-17 Poniard Pharmaceuticals, Inc. Synthesis of picoplatin
RU2451010C1 (ru) * 2011-01-11 2012-05-20 Закрытое Акционерное Общество "Ива Фарм" Палладиево-медные катализаторы гомогенного селективного окисления тиольных групп, комбинация и композиция на их основе и способ терапевтического воздействия
CN103554188B (zh) * 2013-11-19 2016-03-02 辽宁大学 6-(氮杂环取代)蒽醌二氯化铂配合物及其制备方法和应用
CN103860539B (zh) * 2014-04-14 2016-02-10 于迎涛 一种具有混合轴向配体的Pt（IV）类抗癌药物及制备方法
CN104231000A (zh) * 2014-08-20 2014-12-24 山东铂源药业有限公司 一种抗肿瘤药物甲啶铂的合成方法
WO2017192290A1 (en) 2016-05-04 2017-11-09 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs
KR102137669B1 (ko) * 2019-08-05 2020-07-27 한국과학기술연구원 메탄올 또는 그 전구체 합성용 촉매, 이의 제조방법 및 이를 이용한 메탄올 또는 그 전구체의 제조방법
EP4736878A2 (en) 2020-07-08 2026-05-06 pharma& Schweiz GmbH Satraplatin for use in the treatment of lymphoid neoplasms
CN113402565B (zh) * 2021-06-16 2023-07-28 中国人民解放军空军军医大学 一类含有泊沙康唑的四价铂配合物、制备方法及其应用
EP4460582A1 (en) 2022-01-07 2024-11-13 pharma& Schweiz GmbH Treating haematological malignancies by means of satraplatin

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329299A (en) * 1979-08-23 1982-05-11 Johnson, Matthey & Co., Limited Composition of matter containing platinum
US4533502A (en) 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
EP0167310B1 (en) * 1984-06-27 1991-05-29 Johnson Matthey Public Limited Company Platinum co-ordination compounds
US5244919A (en) 1988-02-02 1993-09-14 Johnson Matthey, Inc. Pt(IV) complexes as anti-tumor agents
SU1790190A1 (ru) * 1990-08-08 1996-04-27 Ленинградский химико-фармацевтический институт Цис-хлордиаммин-1,3-диметилксантинплатины (ii) хлорид дигидрат, проявляющий противоопухолевую активность
GB9105037D0 (en) 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
RU2050361C1 (ru) * 1991-12-23 1995-12-20 Юрий Михайлович Островский Пентахлороплатинат (iv)-4- метил-3-[(2- метил-4- окси-5-пиримидинил) метил-]-5-(2 -оксиэтил)тиазолия, проявляющий противоопухолевую активность
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
US5547982A (en) * 1995-02-27 1996-08-20 Johnson Matthey, Inc. Anti-tumor platinum complexes
RU2089555C1 (ru) * 1995-05-04 1997-09-10 Новосибирский институт биоорганической химии СО РАН Бисимидазол-(1,10)-фенантролинплатина (iii) дихлорид, проявляющий цитостатическую противоопухолевую активность
AU3268500A (en) 1999-03-19 2000-10-09 Anormed Inc. Pharmaceutical compositions comprising metal complexes
CN1916009B (zh) 1999-04-13 2010-12-15 阿诺麦德股份有限公司 制备胺铂配合物的方法

Also Published As

Publication number Publication date
KR20020018189A (ko) 2002-03-07
HUP0200748A2 (hu) 2002-07-29
NO20014957L (no) 2001-12-03
EE200100536A (et) 2003-02-17
ATE309257T1 (de) 2005-11-15
RU2245340C2 (ru) 2005-01-27
CN1847253A (zh) 2006-10-18
NO20014957D0 (no) 2001-10-12
CN100460412C (zh) 2009-02-11
CN1916009A (zh) 2007-02-21
CA2368849A1 (en) 2000-10-19
NO330429B1 (no) 2011-04-11
CA2368849C (en) 2011-01-25
CN1350540A (zh) 2002-05-22
HUP0200748A3 (en) 2010-01-28
AU770006B2 (en) 2004-02-12
AU3951000A (en) 2000-11-14
IL145671A0 (en) 2002-06-30
PL202731B1 (pl) 2009-07-31
PL351612A1 (en) 2003-05-05
CN1916009B (zh) 2010-12-15
BR0009780B1 (pt) 2013-09-24
CY1104965T1 (el) 2010-03-03
CZ20013648A3 (cs) 2002-02-13
SK286374B6 (sk) 2008-08-05
DE60023859D1 (de) 2005-12-15
TWI289565B (en) 2007-11-11
ES2253214T3 (es) 2006-06-01
IS2709B (is) 2011-01-15
IS2711B3 (is) 2011-01-15
BR0009780A (pt) 2002-01-02
DE60023859T2 (de) 2006-08-03
MY122706A (en) 2006-04-29
IS6092A (is) 2001-09-28
UA71614C2 (en) 2004-12-15
ZA200107965B (en) 2003-01-02
WO2000061590A1 (en) 2000-10-19
EE04747B1 (et) 2006-12-15
EP1165576B1 (en) 2005-11-09
KR100711955B1 (ko) 2007-05-02
BG65429B1 (bg) 2008-07-31
EP1165576A1 (en) 2002-01-02
JP4756669B2 (ja) 2011-08-24
MXPA01010430A (es) 2002-03-27
HK1100562A1 (en) 2007-09-21
SK14682001A3 (sk) 2002-01-07
AR043084A1 (es) 2005-07-20
HK1039336A1 (en) 2002-04-19
JP2002541263A (ja) 2002-12-03
US6518428B1 (en) 2003-02-11
NZ514736A (en) 2004-01-30
CN1250559C (zh) 2006-04-12
DK1165576T3 (da) 2006-03-27
BG106090A (en) 2002-06-28
CZ303156B6 (cs) 2012-05-09

Similar Documents

Publication Publication Date Title
EP1165576B1 (en) Process for preparing amine platinum complexes
Casini et al. Synthesis, characterisation and biological properties of gold (III) compounds with modified bipyridine and bipyridylamine ligands
Banu et al. Catechol oxidase activity of dinuclear copper (II) complexes of Robson type macrocyclic ligands: Syntheses, X-ray crystal structure, spectroscopic characterization of the adducts and kinetic studies
Lempers et al. Characterization of products from chloro (diethylenetriamine) platinum (1+) chloride and S-adenosyl-L-homocysteine. Evidence for a pH-dependent migration of the platinum moiety from the sulfur atom to the amine group and vice versa
CN113816999B (zh) 咖啡因衍生的氮杂环卡宾钯配合物及其合成方法与催化应用
EP2243773B1 (en) Platinum complex compound and utilization of the same
HK1100562B (en) Process for preparing amine platinum complexes
CN104230997B (zh) 一种铂（ⅱ）配合物、其制备方法、药物组合物及应用
Sykes et al. Vitamin B6 model reactions. 4. Stereoelectronic catalysis of carbon-hydrogen bond-breaking reactions and crystal and molecular structure of tetramethylammonium bis (pyridoxylideneglycinato) cobaltate (III)-4.5-water
Dong et al. Anionopentaaminecobalt (III) complexes with polyamine ligands. XII. Geometric and chiral interconversions associated with the coordination of N-methyl-1, 3-diaminopropane in Isomers of chloro and aqua (N-methyl-1, 3-diaminopropane)(diethylenetriamine) cobalt (III) complexes
Yoshinari et al. Synthesis, characterization, and Crystal Structures of Cis and trans isomers of a platinate (II) complex with d-Penicillaminate
CN121824635A (zh) 一种香豆素-酰肼基半三明治型铱和钌配合物的制备方法与应用
Rossignoli et al. A Saturated Heterocycle Formed from Ethane-1, 2-diamine, Formaldehyde and Nitroethane: Crystal Structure of 6-Methyl-6-nitro-1, 4-bis (2′-nitropropan-1′-yl)-1, 4-diazacycloheptane
Sen' et al. Synthesis of Dinitroxyl cis-Diaminoplatinum (II) Complexes and their Interaction with DNA